関連する実験動画

Updated: Jun 7, 2026

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development
12:53

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development

Published on: March 16, 2022

スクラブチフスワクチン;大規模生産

F E BUCKLAND, A DUDGEON

    Lancet (London, England)
    |October 29, 2010
    PubMed
    まとめ

    No abstract available in PubMed .

    キーワード:
    RICKETTSIA/ワクチンについてツツガムシの病気/ワクチン

    さらに関連する動画

    Micro-Colony Forming Unit Assay for Efficacy Evaluation of Vaccines Against Tuberculosis
    06:26

    Micro-Colony Forming Unit Assay for Efficacy Evaluation of Vaccines Against Tuberculosis

    Published on: July 28, 2023

    Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
    10:58

    Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

    Published on: August 21, 2019

    関連する実験動画

    Last Updated: Jun 7, 2026

    Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development
    12:53

    Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development

    Published on: March 16, 2022

    Micro-Colony Forming Unit Assay for Efficacy Evaluation of Vaccines Against Tuberculosis
    06:26

    Micro-Colony Forming Unit Assay for Efficacy Evaluation of Vaccines Against Tuberculosis

    Published on: July 28, 2023

    Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
    10:58

    Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation

    Published on: August 21, 2019

    関連する概念動画

    Vaccine Production01:23

    Vaccine Production

    Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
    Smallpox01:24

    Smallpox

    Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
    Vaccinations01:51

    Vaccinations

    Overview

    共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

    Transmission of HTLV-I and HIV among homosexual men in Trinidad.

    JAMA·1987

    1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

    Lancet (London, England)·2026

    Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

    Lancet (London, England)·2026

    Advancing the relevance of clinical trials for older patients.

    Lancet (London, England)·2026

    Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

    Lancet (London, England)·2026

    Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

    Lancet (London, England)·2026

    Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

    Lancet (London, England)·2026

    Growth and physiological responses of wheat to diammonium phosphate fertilizer coated with Fe and Zn doped TiO<sub>2</sub> nanoparticles.

    3 Biotech·2026

    Genome Editing Approaches in Flax (<i>Linum usitatissimum</i> L.): From Tools to Trait Improvement.

    International journal of molecular sciences·2026

    On the verge of zoonosis: Mechanisms and risks of parasite spillover.

    Advances in parasitology·2026

    Stable Agrobacterium-mediated transformation system for Flammulina filiformis using Geneticin (G418) as efficient selection agent.

    Microbiological research·2026

    Engineering a Bicistronic Expression System for Mammalian Cell-Based Production of Biofunctional Recombinant Follicle Stimulating Hormone (FSH) of Bos Indicus Origin.

    Biotechnology journal·2026

    Markerless large DNA integration in Lactococcus lactis through the coupling of homologous single-crossover and Cre/loxP system.

    Journal of biotechnology·2026
    関連記事をすべて見る
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    JoVEについて
    概要リーダーシップブログJoVEヘルプセンター
    著者向け
    出版プロセス編集委員会範囲と方針査読よくある質問投稿
    図書館員向け
    推薦の声購読アクセスリソース図書館諮問委員会よくある質問
    研究
    JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
    教育
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
    利用規約
    プライバシーポリシー
    ポリシー
    Jove
    Visualize
    お問い合わせ